Immunovative, Inc. - Sec Filings Immunovative, Inc.
  Immunovative Linked In Immunovative Facebook
Download Immunovative Information
Symbol:IMUN
For more information: 514-840-3697
SEC Filings

11/19/2012
11/16/2012
11/13/2012
11/07/2012
10/30/2012
10/29/2012
10/18/2012
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP) 09/17/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP) 08/28/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP) 08/27/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP) 08/14/12
IMMUNOVATIVE, INC.  07/16/12
IMMUNOVATIVE, INC.  06/29/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  03/29/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  02/29/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  02/21/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  02/14/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  01/27/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  01/11/12
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  12/15/11
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  11/21/11
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  11/14/11
IMMUNOVATIVE, INC.(NOVO ENERGIES CORP)  10/03/11
  Read Archived Filings  

 

Latest News about Cancer TreatmentsLATEST NEWS
Nov.
29
2012
Immunovative Announces Regulatory Clearance to Conduct a Phase II/III Clinical Trial in Advanced Metastatic Breast Cancer for AlloStim(TM)
Read more
Nov.
27
2012
Dr. Michael Har-Noy to Present at the Inaugural European Immunotherapy and Cancer Vaccine Congress in Brussels, Belgium Read more
  View More>
 
Latest News about Cancer TreatmentsLATEST VIDEOS
The Montreal University Club Montreal Conference
Part One

Watch Video
The Montreal University Club Montreal Conference
Part Two

Watch Video
IMUN Video Intro Presentation IMUN Video Intro Presentation
Watch Video